Shinobi Therapeutics Revenue and Competitors

South San Francisco, CA USA

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Shinobi Therapeutics has 31 Employees.(i)
  • Shinobi Therapeutics grew their employee count by 72% last year.

Shinobi Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M80%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1731%N/AN/A
Add Company

What Is Shinobi Therapeutics?

Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less

keywords:N/A

N/A

Total Funding

31

Number of Employees

N/A

Revenue (est)

72%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M31-9%N/A
#2
$23.4M31-65%N/A
#3
$15M310%$3.5M
#4
N/A3233%N/A
#5
$5M32-14%N/A